What Fenules 100 Treats: Main Uses and Benefits

Fenules 100 is commonly used as a therapeutic nutritional agent to manage states of iron deficiency across various clinical and physiological contexts. Its use is generally focused on replenishing the body's iron stores, an action that contributes to the production of blood components.

The primary therapeutic role of Fenules 100 is the management of iron deficiency anemia and latent iron deficiency, where stores are depleted but full anemia has not yet developed. This therapy contributes to easing the systemic manifestations linked to low oxygen transport capacity. This treatment may assist in managing the risk of latent deficiency progressing into symptomatic anemia, contributing to easing the long-term impact of iron-deficient states on overall health.

Indications for its use often include low iron status due to chronic blood loss, increased physiological needs during pregnancy and lactation, or nutritional restrictions. By addressing the systemic imbalance, the medication is applied to address the symptoms of iron deficiency, chiefly persistent fatigue, general weakness, and the accompanying loss of physical endurance.

Quick Fact: Supports Management of Constitutional Fatigue

Regulatory References

1. NIH MedlinePlus overview on Iron Deficiency Anemia

Eligibility Map: Who Can and Cannot Use Fenules 100 — Official Regulatory Information

The eligibility profile for Fenules 100, an oral iron supplement, is defined by strict regulatory exclusions concerning iron metabolism, component sensitivity, and age-related safety risk.

Eligibility Scope

Eligibility Classifications (High-Level)

Resulting Eligibility Structure

Official regulatory documents strictly define eligibility by creating absolute prohibitions against use in populations where iron accumulation poses a risk, specifically in cases of iron overload syndromes or non-iron deficiency anemias. Use is also contraindicated in patients with active severe gastrointestinal disease or known hypersensitivity to the components. Furthermore, the medicine is prohibited for children under six years due to the mandatory label warning concerning fatal accidental iron poisoning. Eligibility is limited to those with confirmed deficiency who do not possess these documented exclusion criteria.

The official interaction profile for Fenules 100 (Ferrous Sulfate and Sodium Ascorbate) is defined by the absorption properties of its components and is organized into regulatory categories that specify constraints on co-administration.

Timing-Based Administration Rules

Co-administration with the following agents requires separating the doses to prevent mutual reduction of drug exposure:

Drug and Substance Interactions

• Decreased Drug Absorption (due to Iron): The ferrous component decreases the absorption of several drugs, including bisphosphonates, levodopa, and methyldopa, which may reduce the bioavailability of these co-administered medicines.
• Reduced Fenules 100 Absorption: The absorption of the ferrous component is reduced by substances such as H2 receptor antagonists, cholestyramine, and Vitamin E.
• Pharmacodynamic Effects: Ascorbic acid is officially noted to increase iron absorption. Additionally, it can cause urine acidification, which may affect the excretion and serum levels of pH-sensitive drugs like amphetamines. Chloramphenicol is noted to increase the patient’s response to iron therapy.

Interaction-Related Restrictions

• Food Restrictions: Oral iron absorption is officially documented to be impaired by co-ingestion with specific foods, including cereals, cheese, coffee, eggs, milk, tea, whole-grain breads, and yogurt.
• Population-Specific Risk: Patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency are noted to be at risk of severe hemolysis from the ascorbic acid component.

Fenules 100 delivers elemental iron in a sustained-release delivery vehicle. After hydrolysis in the gastrointestinal tract, the iron cation is absorbed primarily in the duodenum and proximal jejunum via two principal transport mechanisms: the Divalent Metal Transporter 1 (DMT1) and the ferroportin export channel, mediated by reduction via duodenal cytochrome B (DcytB). The iron is then bound to transferrin for transport in the systemic circulation. Systemically, iron is utilized as a constituent in the synthesis of the heme prosthetic group, which is an essential component of hemoglobin in erythroid precursor cells within the bone marrow. Iron incorporation into hemoglobin facilitates the protein’s tertiary and quaternary structure, enabling its primary physiological function: reversible oxygen binding and transport from the pulmonary circulation to peripheral tissues. Iron is also integrated into myoglobin in muscle tissue and serves as a cofactor for various essential enzymes involved in electron transport and cellular energy metabolism. This mechanism modulates systemic oxygen-carrying capacity.

Official Administration Guidelines for Fenules 100

The usage of Fenules 100, an oral combination product containing Ferrous Sulfate and an absorption enhancer, follows structured protocols for iron therapy. This medication is administered via the oral route in the form of a capsule or tablet, often utilizing an extended-release delivery system.

This procedural structure ensures the dose is delivered through the correct route and at the proper frequency and duration, according to standard clinical frameworks for iron replacement therapy.

Research Evidence / Overview of Studies for Fenules 100

Evidence for Use in Iron Deficiency Anemia (IDA)

The foundation of the research for this oral iron supplementation product involves Randomized Controlled Trials (RCTs) and Systematic Reviews that evaluate oral iron preparations in adults and children with Iron Deficiency Anemia (IDA). These studies were designed to monitor the patterns observed following oral iron supplementation and their relationship to systemic or functional imbalance, specifically focusing on the blood markers that define iron status.

Researchers primarily examined changes in the concentration of Hemoglobin (Hb), which reflects oxygen-carrying capacity, and levels of Ferritin, which is a key marker for iron stores. Studies describe patterns related to measured changes in these blood markers that were observed in the study populations over defined time intervals.

Evidence for Use in Anemia Prevention During Pregnancy

Research specifically explored the use of oral iron supplementation for prophylaxis (prevention) of anaemia and iron deficiency risk in pregnant populations. This evidence primarily comes from Systematic Reviews and Meta-Analyses of RCTs where women were monitored throughout their pregnancy.

The studies monitored outcomes related to systemic or functional imbalance by measuring the recorded incidence of Maternal Anaemia at Term and Iron Deficiency at Term. Findings describe patterns observed in the studies involving the measured incidence of maternal anaemia. However, certainty remains low regarding the research describing the impact on certain critical infant outcomes, indicating data are still emerging.

Examination of the Formulation: Iron Plus Ascorbate

Research examined the formulation of this oral iron supplement in studies where the Ascorbate component was included as a research variable. Many trials compared iron formulations that included Vitamin C against iron supplements used alone. Some systematic reviews described patterns where the addition of the Ascorbate component was associated with measured changes in hemoglobin and ferritin levels. However, other large-scale RCTs described patterns where the measured changes in hemoglobin recovery were similar when comparing iron alone to iron plus Vitamin C. This demonstrates that findings were mixed across studies regarding the clinical importance of the combination for these specific blood markers.

What is Still Uncertain About the Research for Fenules 100

Uncertainty remains regarding the exact clinical relevance of the Ascorbate component in the combination. The available evidence quality varies across studies, and one key limitation is the heterogeneity of the research: studies used various iron salts and different doses and schedules, which can make direct comparisons challenging. Additionally, subgroup findings are uncertain, as much of the existing data is aggregated, meaning that results apply only to the general populations studied, and findings concerning specialized groups or severe cases are limited.

Key Studies & References

1. Efficacy of Vitamin C with Iron Supplementation in Iron Deficiency Anemia Patients: A Systematic Review and Meta-Analysis (ASH 2023)
2. Regulatory Review: Ferrous Sulfate and Sodium Ascorbate combination claims (TGA FOI 1036)

Common questions about Fenules 100 (FAQ)

Q: How quickly is Fenules 100 expected to start working?

Official guidance suggests that measured changes in blood markers and patient-reported improvements may begin to be observed after about 3 to 4 weeks of use. However, the primary goal of fully replenishing iron stores may take longer, often between two to four months.

Q: Is Fenules 100 safe for long-term use?

The typical course for treating iron deficiency is defined as several months, commonly three to six months after blood levels normalize. Regulatory warnings focus on the need for medical supervision and monitoring for use that extends past the typical treatment period, to watch for side effects and risks like iron accumulation.

Q: Can Fenules 100 be used by people with kidney issues?

Official information requires caution when the product is used by individuals who have renal impairment (kidney issues). The decision to use it requires evaluation by a healthcare provider.

Q: Can Fenules 100 be used by people with liver conditions?

Official prescribing information does not list liver conditions (hepatic impairment) as a direct contraindication for use. However, due to component risks noted in some safety documents, the decision to use the product in patients with existing liver conditions should be made by a healthcare provider.

Q: Can people with high blood pressure use Fenules 100?

The official prescribing information for Fenules 100 does not list high blood pressure (hypertension) as a contraindication or required caution for use.

Q: Can people with diabetes use Fenules 100?

Official information does not list diabetes as a contraindication for using Fenules 100. It is noted, however, that the Ascorbate (Vitamin C) component can potentially interfere with the results of certain clinical lab tests, such as some glucose measurements, which may be relevant for people managing diabetes.

Q: Is it normal to feel a mild stomach upset when starting Fenules 100?

Official regulatory information describes gastrointestinal effects like nausea, constipation, and diarrhea as common side effects with oral iron supplements. These effects are often noted to be more pronounced when first beginning therapy.

Q: Why might a person not be eligible to use Fenules 100?

The medication is contraindicated (officially prohibited) to prevent toxic iron accumulation in people who have existing iron overload syndromes or forms of anemia not caused by iron deficiency. Use is also prohibited for children under six years old due to the critical risk of fatal accidental iron poisoning.

Q: What is the difference between an 'adverse reaction' and a 'side effect' for Fenules 100?

In regulatory documents, these terms are often used interchangeably to describe unwanted effects reported during clinical use. Both refer to effects that are officially classified by how frequently they occur, such as being 'Common' or 'Rare'.

Q: Is Fenules 100 a type of antibiotic?

No. Official documents classify Fenules 100 as a Hematinic and an Oral Iron Supplement. It belongs to the class of products used to promote healthy blood components, not to treat bacterial infections.

Q: What is the difference between Fenules 100 and similar sounding medicines?

Fenules 100 is a specific combination product that contains Ferrous Sulfate (the iron source) and the absorption enhancer Sodium Ascorbate (Vitamin C). Other oral iron supplements may use different iron salts (like fumarate or gluconate) or may not include the Vitamin C component.

Q: Will Fenules 100 cause drowsiness or affect driving?

Official safety documents and adverse reaction classifications do not list drowsiness or any other central nervous system effects that would affect a person's ability to drive as a common or specific side effect.

Q: Is Fenules 100 considered a controlled substance?

No. Official US regulatory information confirms that Ferrous Sulfate and its combination products are not classified as controlled substances under any federal drug schedule.

Q: Are there specific age limits for who can use Fenules 100?

Yes. Due to the risk of accidental poisoning, use is strictly prohibited for children under 6 years of age. Furthermore, if the product is in a capsule form, use is often not recommended for children under 12 years.

Q: Can Fenules 100 affect the results of lab tests?

Yes, the Ascorbate component of the product is known to potentially interfere with the results of certain clinical lab tests. This includes tests for blood glucose, creatinine, and occult blood in the stool.

Q: Is Fenules 100 the same as other brands with a similar active ingredient?

Fenules 100 contains the common ingredient Ferrous Sulfate but is distinguished by its specific combination with the absorption enhancer Sodium Ascorbate. While other products may contain these components, the availability of an exact generic equivalent to this specific combination and extended-release format will vary by market.

Q: Does taking Fenules 100 affect birth control effectiveness?

Official drug interaction information suggests that the Ascorbic Acid component may increase the serum levels of estrogens found in some oral contraceptives. Also, if the product causes severe gastrointestinal issues like vomiting or diarrhea, the effectiveness of oral contraceptives may be indirectly affected.

Q: Is it possible to be allergic to Fenules 100?

Yes. Official safety data mentions a rare risk of severe hypersensitivity (a strong allergic reaction, such as anaphylaxis). Having a known hypersensitivity to any component is listed as a regulatory contraindication for use.

Q: Are there common signs of a serious reaction to Fenules 100?

Signs of a severe hypersensitivity reaction include symptoms of anaphylaxis. Signs of potential acute iron overdose (a critical safety warning) can include lethargy, severe stomach pain, weak and rapid pulse, or persistent vomiting. Any suspected serious reaction, such as signs of anaphylaxis or iron overdose, is a documented medical emergency.

Q: Does Fenules 100 have any official warnings related to mental health?

The official safety profile and adverse reaction classifications, which focus on gastrointestinal, immune system, and overdose risks, do not list official warnings related to psychiatric or mental health.

Q: Is there a generic version of Fenules 100 available?

The two main components, Ferrous Sulfate and Sodium Ascorbate, are available generically and often over-the-counter (OTC). While other combination products exist, the availability of an exact generic equivalent to this specific formulation, Fenules 100, will vary depending on your location.

Q: Are the side effects of Fenules 100 permanent?

Official information describes common side effects (like nausea and constipation) as often being more pronounced at the initiation of therapy. This framing suggests that most common side effects are temporary and may improve with continued use or resolve upon stopping the medication.

Q: Does Fenules 100 work on symptoms or the underlying cause?

Regulatory documents describe the drug as an oral iron supplement prescribed to address the underlying cause of iron deficiency. By restoring iron reserves, it enables the body to produce enough hemoglobin, which then leads to the relief of related symptoms like fatigue.

Q: Is there a maximum length of time Fenules 100 should be used?

The typical duration of use is several months (3 to 6 months) to fully replenish stores. While no universal maximum cutoff is defined, regulatory warnings focus on the risk of iron overload, stressing the need for medical supervision and monitoring for use that extends past the period needed to correct a deficiency.

Q: Are there any common supplements that should be avoided while using Fenules 100?

Yes. The absorption of the ferrous component is officially documented to be reduced by co-ingestion with Vitamin E, which is found in many supplements. Additionally, dietary components such as calcium, zinc, and magnesium can reduce the absorption of iron.

Q: Are there studies examining Fenules 100 use in the elderly?

Existing research predominantly focuses on general adult populations, pregnant women, and children. Research evidence has noted that findings concerning specialized subgroups, such as the elderly population, are often limited or uncertain.

Q: Is Fenules 100 generally well tolerated?

The product is formulated with an extended-release system designed specifically to mitigate the gastrointestinal challenges often associated with high-dose iron. However, common GI side effects like nausea and constipation are still documented in the official safety profile.

Q: Can Fenules 100 be used to treat anxiety?

No. The medication is classified solely as an oral iron supplement and hematinic. It is officially indicated only for the treatment and prevention of iron deficiency and related anemia.

Q: How is Fenules 100 typically eliminated from the body?

Most of the absorbed iron is conserved and reused by the body, mainly for forming hemoglobin. The body typically loses very small amounts of unabsorbed iron through feces, hair, nails, and urine.

How to Store and Dispose of Fenules 100?

Fenules 100 must be stored at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F). The medicine must be kept in a cool, dry place and protected from moisture, while also being protected from excessive heat.

Storage and Safety

It is mandatory to store the product in its original container to maintain proper conditions. A critical safety requirement for this iron-containing medicine is to keep it out of the sight and reach of children, as accidental overdose of iron products is a leading cause of poisoning in children under six.

Disposal

The product must be disposed of by the expiration date on the package. Any unused or expired Fenules 100 should be discarded strictly according to local requirements for pharmaceutical waste.